Four widely used Central Nervous System medications, including Zopiclone and Gabapentin, have been placed under Schedule H1 controls amid concerns over over-the-counter availability and off-label intoxication. Chemists will have to follow stricter prescription, record-keeping and warning-label requirements for these drugs.
